ATE195065T1 - Biologisch abbaubarer sklerastopfen - Google Patents

Biologisch abbaubarer sklerastopfen

Info

Publication number
ATE195065T1
ATE195065T1 AT94907661T AT94907661T ATE195065T1 AT E195065 T1 ATE195065 T1 AT E195065T1 AT 94907661 T AT94907661 T AT 94907661T AT 94907661 T AT94907661 T AT 94907661T AT E195065 T1 ATE195065 T1 AT E195065T1
Authority
AT
Austria
Prior art keywords
drug
sclera
surgical operation
vitreous body
plug
Prior art date
Application number
AT94907661T
Other languages
English (en)
Inventor
Yuichiro Ogura
Yoshito Ikada
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE195065T1 publication Critical patent/ATE195065T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00781Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00004(bio)absorbable, (bio)resorbable or resorptive

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94907661T 1993-02-26 1994-02-23 Biologisch abbaubarer sklerastopfen ATE195065T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6281493 1993-02-26
JP6945793 1993-03-04
PCT/JP1994/000273 WO1994018921A1 (en) 1993-02-26 1994-02-23 Biodegradable sclera plug

Publications (1)

Publication Number Publication Date
ATE195065T1 true ATE195065T1 (de) 2000-08-15

Family

ID=26403867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907661T ATE195065T1 (de) 1993-02-26 1994-02-23 Biologisch abbaubarer sklerastopfen

Country Status (12)

Country Link
EP (1) EP0654256B1 (de)
KR (1) KR100313268B1 (de)
AT (1) ATE195065T1 (de)
CA (1) CA2118515A1 (de)
DE (1) DE69425411T2 (de)
DK (1) DK0654256T3 (de)
ES (1) ES2150487T3 (de)
FI (1) FI945014A0 (de)
GR (1) GR3034526T3 (de)
NO (1) NO303665B1 (de)
PT (1) PT654256E (de)
WO (1) WO1994018921A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0992244A4 (de) * 1997-07-02 2001-01-17 Santen Pharmaceutical Co Ltd Sklerastopfen aus polymilchsäure
US6991650B2 (en) 1997-10-08 2006-01-31 Refocus Ocular, Inc. Scleral expansion device having duck bill
US7008396B1 (en) 1999-09-03 2006-03-07 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US6375642B1 (en) * 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP1637126B1 (de) * 2000-07-05 2016-12-14 Allergan, Inc. Verfahren zur Behandlung von entzündungsbedingten Zuständen der Augen
WO2002043785A2 (en) 2000-11-29 2002-06-06 Oculex Pharmaceuticals, Inc. Intraocular implants for preventing transplant rejection in the eye
US20040137059A1 (en) 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
JP5006651B2 (ja) 2003-12-05 2012-08-22 ブリストル−マイヤーズ スクウィブ カンパニー 2型血管内皮増殖因子受容体の阻害剤
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
MX2009000378A (es) 2006-07-11 2009-08-12 Refocus Group Inc Protesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y metodos relacionados.
EP2121743B1 (de) 2006-11-22 2015-06-03 Bristol-Myers Squibb Company Gezielte therapeutika auf der basis von manipulierten proteinen für tyrosinkinaserezeptoren, einschliesslich igf-ir
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
KR20100128291A (ko) 2008-02-14 2010-12-07 브리스톨-마이어스 스큅 컴퍼니 Egfr에 결합하는 조작된 단백질을 기초로 하는 표적화된 치료제
CN102099373A (zh) 2008-05-22 2011-06-15 百时美施贵宝公司 基于纤连蛋白的多价支架结构域蛋白
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之egfr/igfir結合分子
ES2573108T3 (es) 2010-05-26 2016-06-06 Bristol-Myers Squibb Company Proteínas de armazón a base de fibronectina que tienen estabilidad mejorada
KR101750651B1 (ko) * 2016-01-28 2017-06-23 동국대학교 산학협력단 약물 잔류 방지능 및 재충전 기능을 갖는 안구 내 약물 주입 장치
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
CN109789011B (zh) * 2016-10-03 2021-09-17 加州理工学院 放射发光光疗眼部设备
EP3746178B1 (de) 2018-01-31 2024-10-16 California Institute of Technology Steuerbare okulare phototherapie
KR20250031766A (ko) 2023-08-29 2025-03-07 주식회사 엠에스씨랩 트로카에 의해 형성된 공막의 천공을 메우기 위한 안과용 실링기구

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4634418A (en) * 1984-04-06 1987-01-06 Binder Perry S Hydrogel seton
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
JPH04364857A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道せき止め用ロッド

Also Published As

Publication number Publication date
DE69425411T2 (de) 2001-02-08
DK0654256T3 (da) 2000-12-18
KR100313268B1 (ko) 2002-11-22
FI945014L (fi) 1994-10-25
NO944060L (no) 1994-10-25
FI945014A7 (fi) 1994-10-25
CA2118515A1 (en) 1994-02-23
NO944060D0 (no) 1994-10-25
EP0654256B1 (de) 2000-08-02
NO303665B1 (no) 1998-08-17
ES2150487T3 (es) 2000-12-01
EP0654256A1 (de) 1995-05-24
EP0654256A4 (de) 1995-01-04
GR3034526T3 (en) 2000-12-29
KR950701209A (ko) 1995-03-23
DE69425411D1 (de) 2000-09-07
WO1994018921A1 (en) 1994-09-01
PT654256E (pt) 2000-12-29
FI945014A0 (fi) 1994-10-25

Similar Documents

Publication Publication Date Title
ATE195065T1 (de) Biologisch abbaubarer sklerastopfen
Tomey et al. The glaucomas in aphakia and pseudophakia
CA1190001A (en) Posterior chamber lens
SE8403090L (sv) Gel for anvendning som glaskroppssubstitut
CA2368335A1 (en) Inflatable device and method for treating glaucoma
DE69422707D1 (de) Verfahren zur verhinderung der trübung der hinteren linsenkapsel
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE343983T1 (de) Ophthalmologisches implantat
DK0403360T3 (da) Anvendelse af phenylethanolaminer til fremstilling af et lægemiddel mod øjenlidelser
SE9101840D0 (sv) New medicinal use
FR2757064B1 (fr) Lentille intraoculaire contenant un medicament relargable
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
Bowman et al. Noninvasive repositioning of a posterior chamber intraocular lens following pupillary capture
CA2396130A1 (en) Preparation of irrigating solution for ocular surgery
Laties et al. The human lens after 48 weeks of treatment with lovastatin
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
RU97105890A (ru) Способ хирургического лечения осложненной катаракты и подвывиха хрусталика, сочетанных с отслойкой сетчатки
RU2003118574A (ru) Дренаж для лечения неоваскулярной глаукомы и способ лечения неоваскулярной глаукомы
PARK et al. Postoperative recurrence rate of scleral fixation technique and bare scleral technique in primary pterygium operation
RU97114014A (ru) Способ предупреждения послеоперационных осложнений при имплантации искусственного хрусталика
YANG et al. The effect of a 5-0 prolene ligation around the Ahmed glaucoma valve tube on the postoperative hypotony
RYU et al. The Effect of Short Term Use of Azopt in Normal Koreans
Scheie et al. Choice of a Miotic Agent Following Retrobulbar Anesthesia
QIU et al. Combined surgery or two-step procedures for the management of primary retinal detachment accompanied with cataract
LG THE NEWER TECHNIQUES IN RETINAL DETACHMENT SURGERY. INDICATIONS FOR THE NEWER METHOD.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee